Nasrat A. Hakim - 29 Mar 2024 Form 4 Insider Report for ELITE PHARMACEUTICALS INC /NV/ (ELTP)

Role
CEO, President, Director, 10%+ Owner
Signature
Nasrat A Hakim
Issuer symbol
ELTP
Transactions as of
29 Mar 2024
Net transactions value
$0
Form type
4
Filing time
02 Apr 2024, 16:58:41 UTC
Previous filing
29 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTP Common Stock Award $0 +49,534,368 +30% $0.000000 216,649,250 29 Mar 2024 Direct F1
holding ELTP Common Stock 2,700,000 29 Mar 2024 by IRA
holding ELTP Common Stock 2,223,147 29 Mar 2024 by Kristine Hakim
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended.